A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Mario Negri Institute for Pharmacological Research
St. Jude Children's Research Hospital
Northwestern University
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center